Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corporation    EW

EDWARDS LIFESCIENCES CORPORATION (EW)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 04/24 10:01:47 pm
134.67 USD   -1.84%
04/24EDWARDS LIFESCI : 1Q Earnings Snapshot
AQ
04/24EDWARDS LIFESCI : Reports First Quarter Results
PR
04/19EDWARDS LIFESCI : quaterly earnings release
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:28pm CEST

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORPO
04/24EDWARDS LIFESCIENCES CORP : Results of Operations and Financial Condition, Finan..
AQ
04/24EDWARDS LIFESCIENCES : 1Q Earnings Snapshot
AQ
04/24EDWARDS LIFESCIENCES : Reports First Quarter Results
PR
04/24EDWARDS LIFESCIENCES CORPORATION : to Host Earnings Call
AC
04/22EDWARDS LIFESCIENCES : To Host Earnings Conference Call On April 24, 2018
AQ
04/19EDWARDS LIFESCIENCES : Patent Issued for Physiologically Harmonized Tricuspid An..
AQ
04/19EDWARDS LIFESCIENCES : Patent Issued for Dry Prosthetic Heart Valve Packaging Sy..
AQ
04/19EDWARDS LIFESCIENCES : Patent Issued for Systems for Deploying Knotless Suture A..
AQ
04/19EDWARDS LIFESCIENCES CORP : quaterly earnings release
04/14EDWARDS LIFESCIENCES : Federal Contracts Awarded by Federal Agencies in Iowa (Ap..
AQ
More news
News from SeekingAlpha
04/24Edwards Lifesciences' (EW) CEO Michael Mussallem on Q1 2018 Results - Earning.. 
04/24After Hours Gainers / Losers (04/24/2018) 
04/24Edwards Lifesciences Q1 top line short of guidance; shares down 8% after hour.. 
04/24Edwards Lifesciences beats by $0.10, beats on revenue 
04/23Notable earnings after Tuesday?s close 
Financials ($)
Sales 2018 3 851 M
EBIT 2018 1 172 M
Net income 2018 951 M
Finance 2018 564 M
Yield 2018 -
P/E ratio 2018 30,08
P/E ratio 2019 27,01
EV / Sales 2018 7,35x
EV / Sales 2019 6,64x
Capitalization 28 881 M
Chart EDWARDS LIFESCIENCES CORPO
Duration : Period :
Edwards Lifesciences Corpo Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Technical analysis trends EDWARDS LIFESCIENCES CORPO
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 146 $
Spread / Average Target 8,5%
EPS Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John P. McGrath Vice President-Quality, Regulatory & Clinical
William J. Link Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES CORPORATION21.63%28 881
THERMO FISHER SCIENTIFIC12.27%86 857
DANAHER CORPORATION7.84%70 780
INTUITIVE SURGICAL22.72%51 587
BOSTON SCIENTIFIC CORPORATION14.97%39 785
ROYAL PHILIPS10.61%37 856